MINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and...

Psilocybin for Depression: A Q&A between Robin Carhart-Harris & a Psilocybin...

Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.

Creso Pharma and Red Light Holland Merge to Introduce The HighBrid...

Mydecine Unveils Artificial Intelligence Drug Discovery Program

Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic Molecule CYB004

Bright Minds Biosciences Announces Application to List on Nasdaq

Whole-Body Effects of Psychedelics – Part 1

Optimi Health Completes Pre-Clinical Trial Application Meeting

PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™...

Load more